Evidence map›Paper›PMID 21238933›Full record

ReviewProgress in molecular biology and translational science2011

Membrane-anchored serine proteases in health and disease.

Toni M Antalis, Thomas H Bugge, Qingyu Wu

Open access · greenAbstract readReview
In one paragraph

Review in Progress in molecular biology and translational science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
28.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 189 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. In Silico Analysis of CMolecules (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Pigs lackingFrontiers in genome editing · 2023
    Article
  18. Identification of a rare Gli1Cell discovery · 2022
    Article
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Toni M AntalisCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Thomas H Bugge
Qingyu Wu
Cleveland Clinic Lerner College of Medicine · USNational Institute of Dental and Craniofacial Research · USUniversity of Maryland, Baltimore · US

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Cell surface serine proteases in development, tissue repair, and malignancyZIADE000699 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI BUGGE, THOMAS H · 2009 to 2025
$34.1M
The cardiac protease corin in natriuretic peptide processing and hypertensionR01HL089298 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI WU, QINGYU · 2008 to 2012
$2.2M
New Function for the Serpin PAI-2 as a Regulator of pRbR01CA098369 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M. · 2003 to 2007
$1.5M
Vascular Remodeling by Membrane Serine ProteasesR01HL084387 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M · 2007 to 2010
$1.5M
Protease Pathways in the Gastrointestinal TractR01DK081376 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M · 2009 to 2010
$675k
NEW FUNCTION SERPIN PAI 2 AS A REGULAR OF RBR56CA098369 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M · 2009 to 2009
$316k
Intramural NIH HHSNCI NIH HHS CA098369NCI NIH HHS P30 CA134274NCI NIH HHS R01 CA098369NCI NIH HHS R56 CA098369NHLBI NIH HHS HL084387NHLBI NIH HHS HL089298NHLBI NIH HHS HL089298-S1NHLBI NIH HHS R01 HL084387NHLBI NIH HHS R01 HL089298NIDDK NIH HHS DK081376NIDDK NIH HHS R01 DK081376
6 · The paper itself

Abstract

Serine proteases of the trypsin-like family have long been recognized to be critical effectors of biological processes as diverse as digestion, blood coagulation, fibrinolysis, and immunity. In recent years, a subgroup of these enzymes has been identified that are anchored directly to plasma membranes, either by a carboxy-terminal transmembrane domain (Type I), an amino-terminal transmembrane domain with a cytoplasmic extension (Type II or TTSP), or through a glycosylphosphatidylinositol (GPI) linkage. Recent biochemical, cellular, and in vivo analyses have now established that membrane-anchored serine proteases are key pericellular contributors to processes vital for development and the maintenance of homeostasis. This chapter reviews our current knowledge of the biological and physiological functions of these proteases, their molecular substrates, and their contributions to disease.

Indexed as

DiseaseHealthAnimalsCell MembraneGlycosylphosphatidylinositolsHumansProtease InhibitorsSerine ProteasesGlycosylphosphatidylinositolsProtease InhibitorsSerine Proteases

Identifiers

PMID21238933
PMCPMC3697097
OpenAlexW1832976650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.